Skip to main content
OpenTrials
Completed

NCT Number: NCT03576560

Selective Use of Antibiotics in Neonates Born to Mothers With Suspected Chorioamnionitis

Retrospective Chart Review to determine the selective use of antibiotics in neonates born to mothers with suspected chorioamnionitis

Completed

Looking for future studies?

Notify Me

Key information

Age range

35 week–42 week

Sex eligibility

Female

Study type

Observational

Primary location

Women's Hospital of Greensboro

Greensboro, North Carolina, 27408-7079, United States

About this study

To determine the incidence and types of adverse outcomes in infants born to mothers with signs of chorioamnionitis when these infants are asymptomatic and are not treated with antibiotics empirically.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Mother/baby dyads in which the mother was diagnosed with chorioamnionitis and/or had intrapartum fever (as diagnosed by obstetrician)

Exclusion criteria

None

Treatment and study plan

Retrospective Chart Review

Other

Retrospective Chart Review

Primary outcomes

  1. Infants born to mother with chorioamnionitis/intrapartum fever as assessed by chart review.

    Time frame: Infants born from July, 2012 to December 31, 2018.

    The retrospective chart review would analyze the total number of infants born to mothers with chorioamnionitis/intrapartum fever.

Sponsors and collaborators

Lead sponsor

Pediatrix

Other

Registry information

Acronym: Chorio

Important dates

Study start
2017
Primary completion
2019
Study completion
2019
First posted
Jul 3, 2018
Registry last updated
Jun 3, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.